Join

or

Existing user? Login

Medicines shortages

HRT shortages prompts guidance on availability

Shortages of hormone replacement therapy (HRT) have prompted the British Menopause Society (BMS) to issue .

Following reports of up to half of HRT products being out of stock, the update on product availability is intended for BMS members, clinicians and patients who may be experiencing difficulties in obtaining HRT supplies.

Haitham Hamoda, chair of the BMS, said there had been “availability issues with many HRT products”.

“Some of these are related to manufacturing shortages, while others are related to supply issues. The BMS has been reassured that these are temporary shortages which pharmaceutical companies and their suppliers are trying to resolve,” he added.

Information on stock availability and supplies was obtained by the BMS from the manufacturers of HRT products.

The products in short supply include Evorel patches, manufactured by Janssen, and some HRT products manufactured by Mylan.

Hamoda said prescribers dealing with shortages “can consider equivalent preparations that provide a similar dose to what their patient is using”.

“If an exact match is not possible, prescribers can seek guidance available on the practical prescribing chart on the and  to clarify equivalent doses,” he added.

Citation: Electronicjuice DOI: 10.1211/PJ.2019.20206936

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00
  • International Research in Healthcare

    Guidance for students or researchers undertaking a multi-centre research project in health services, medicines use and professional practice.

    £38.00
  • Medicines Use Reviews

    Conduct successful Medicines Use Reviews (MURs) with this comprehensive book. Contains evidence-based information, tips and guidance.

    £27.00
  • Rules and Guidance for Pharmaceutical Manufacturers and Distributors 2017 (The Orange Guide)

    Commonly known as the Orange Guide, this book is an essential reference for all involved in the manufacture or distribution of medicines in Europe.

    £82.00
  • Rules and Guidance for Pharmaceutical Distributors 2017 (The Green Guide)

    Essential guidance for distributors of medicines for human use in Europe, compiled by the MHRA.

    £72.00

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.